Evidence map›Paper›PMID 34589327›Full record

ArticleCureus2021

Acute Mycophenolate Mofetil Overdose Managed Conservatively.

Prabhat Sharma, Ashish Guragain, Sunil Adhikari, Subash Dahal, Bibek Dhungana

Abstract readCase Reports
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Prabhat SharmaInternal Medicine, Shankarapur Hospital, Kathmandu, NPL.
Ashish GuragainInternal Medicine, Manipal College of Medical Sciences, Pokhara, NPL.
Sunil AdhikariGeneral Practice and Emergency, Patan Academy of Health Sciences, Lalitpur, NPL.
Subash DahalInternal Medicine, Shankarapur Hospital, Kathmandu, NPL.
Bibek DhunganaInternal Medicine, KIST Medical College, Lalitpur, NPL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycophenolate mofetil (MMF) is an immunosuppressant drug widely used in post-transplant patients and the treatment of various inflammatory conditions. It is considered a relatively safe drug with minimal adverse effects. We managed an acute overdose of 19 grams (g) of MMF with a suicidal intention in a 17-year-old female with no significant past medical history. Apart from episodes of mild headaches, she did not develop other symptoms, laboratory abnormalities, or complications.

Indexed as

adverse effectsmycophenolate mofetilmycophenolic acidoverdosepoisoningtoxicity

Identifiers

PMID34589327
PMCPMC8459915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.